Amorepacific and Viol Medical Forge Partnership to Fuse Beauty with Medical Devices

Amorepacific and Viol Medical Sign MOU for Collaborative Innovation

On March 27, 2026, Amorepacific, a leader in the beauty industry, announced an exciting new partnership with Viol Medical, a company specializing in energy-based medical devices. This collaboration sets the stage for significant advancements in both the beauty and medical device sectors, as the two companies aim to integrate their respective expertise for the mutual benefit of consumers and the market.

The essence of this partnership lies in a memorandum of understanding (MOU) that signifies Amorepacific's commitment to expanding its product lineup by merging its pioneering skincare knowledge with Viol Medical's innovative technology. By aligning their strengths, the companies plan to develop new products that will blend advanced skincare solutions with cutting-edge device technology.

This collaboration aims to create a seamless experience for consumers, bridging the gap between professional beauty treatments and at-home solutions. Amorepacific, with its long-standing history and expertise in skin science, is set to leverage its extensive research capabilities and brand assets. According to Sean Kim, CEO of Amorepacific, the goal is to connect professional treatment settings with everyday home care. He expressed optimism for the partnership, stating that it will allow them to deliver new beauty solutions to a global audience.

Viol Medical, founded in 2009, has been at the forefront of creating microneedle radiofrequency (RF)-based devices used in aesthetic and medical treatments. With a portfolio that includes products like Sylfirm X, Scarlet, CELLINEW, and DUOTITE, Viol Medical has established itself as a prominent player in the med-tech industry. Eunchun Lee, CEO of Viol Medical, sees the partnership with Amorepacific as a chance to tap into the expertise and recognition that Amorepacific commands in the beauty sector, ultimately advancing the integration of beauty and medical innovations within global markets.

Furthermore, this MOU comes with Amorepacific making a strategic investment into Viol Medical, showcasing a strong commitment to the partnership. The collaboration aims to foster long-term opportunities as the beauty and medical sectors continue to converge, reflecting a growing trend toward holistic beauty solutions that are effective and backed by scientific prowess.

Amorepacific, widely recognized as Korea's leading beauty company, is renowned for its innovative skincare, makeup, haircare, and wellness brands. The company's commitment to pioneering research dates back to its establishment, making it a household name in K-beauty innovation. As the company ventures further into collaborations like this one, it exemplifies a forward-thinking approach that prioritizes merging beauty with scientific advancements for enhanced consumer satisfaction.

With this MOU, both Amorepacific and Viol Medical are poised to transform how beauty treatments are perceived and delivered globally, paving the way for innovative solutions that cater to the evolving needs of consumers. As they embark on this journey together, they are not just redefining beauty but also setting new standards in the synergy between health and aesthetics.

In conclusion, the partnership between Amorepacific and Viol Medical marks a significant milestone in the beauty industry, where the integration of advanced medical device technology into everyday beauty routines is positioned to set new benchmarks. This strategic alliance is an exciting development for both industries, promising to deliver innovative solutions that enhance beauty while prioritizing consumer well-being.